A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and clinical applications without systematic search or meta-analytic methodology.
PubMed 32121367 · doi:10.3390/nu12030665
What was done
This narrative review summarizes existing research on the biological mechanisms and clinical applications of zinc-L-carnosine (polaprezinc). The authors evaluate its effects on damaged epithelial cells, focusing on mucosal lining restoration, gastric ulcers, gastrointestinal disorders, taste disorders, and radiation- or chemotherapy-induced oral mucositis in cancer patients.
What was found
The abstract reports no quantitative data, sample sizes, or effect estimates. It qualitatively describes zinc-L-carnosine as operating through localized anti-inflammatory and antioxidant mechanisms to protect and restore mucosal and epithelial tissues, supporting its approved use for gastric ulcers in Japan and suggesting utility in oral mucositis.
Why it matters
Oral mucositis is a frequent and debilitating complication of cancer therapy that often disrupts treatment. This paper highlights zinc-L-carnosine as a supportive-care agent for protecting and repairing epithelial integrity across the gastrointestinal tract.
Limits
As a narrative review, it lacks a systematic search protocol, predefined inclusion criteria, risk-of-bias evaluation, and quantitative pooling. The abstract provides no specific patient numbers, numerical outcomes, effect sizes, or detailed safety data.
Cited by
- supports Zinc carnosine promotes the healing of the gastrointestinal gut lining.
- supports Zinc carnosine has a unique therapeutic mechanism for treating gastric ulcers.